Axecap Investments LLC Acquires Shares of 173,016 Phibro Animal Health Co. (NASDAQ:PAHC)

Axecap Investments LLC acquired a new stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 173,016 shares of the company's stock, valued at approximately $3,696,000. Phibro Animal Health comprises approximately 3.1% of Axecap Investments LLC's holdings, making the stock its 8th biggest holding. Axecap Investments LLC owned about 0.43% of Phibro Animal Health as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the company. Millennium Management LLC increased its holdings in shares of Phibro Animal Health by 233.0% in the fourth quarter. Millennium Management LLC now owns 207,749 shares of the company's stock valued at $4,363,000 after purchasing an additional 145,359 shares during the period. Jacobs Levy Equity Management Inc. increased its holdings in Phibro Animal Health by 56.7% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company's stock worth $6,325,000 after buying an additional 108,918 shares during the period. Hussman Strategic Advisors Inc. acquired a new position in Phibro Animal Health in the 4th quarter worth approximately $2,205,000. Nuveen Asset Management LLC increased its holdings in Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after buying an additional 103,618 shares during the period. Finally, Alliancebernstein L.P. increased its holdings in Phibro Animal Health by 357.1% in the 4th quarter. Alliancebernstein L.P. now owns 130,000 shares of the company's stock worth $2,730,000 after buying an additional 101,560 shares during the period. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Price Performance

PAHC stock traded up $0.12 during mid-day trading on Thursday, reaching $24.51. 174,465 shares of the company's stock were exchanged, compared to its average volume of 204,227. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a 12-month low of $16.16 and a 12-month high of $26.55. The stock's 50 day moving average is $21.01 and its 200 day moving average is $21.90. The company has a market cap of $993.49 million, a price-to-earnings ratio of 51.06, a price-to-earnings-growth ratio of 0.45 and a beta of 0.74.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. The firm had revenue of $347.80 million for the quarter, compared to analyst estimates of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, research analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 annualized dividend and a dividend yield of 1.96%. Phibro Animal Health's dividend payout ratio (DPR) is presently 61.54%.

Wall Street Analysts Forecast Growth

PAHC has been the subject of a number of research reports. Morgan Stanley boosted their target price on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research report on Thursday, May 8th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $20.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.